US Stem Cell Inc (USRM)

[kgnadt]

Thanks for the pastes from Pacer. Just took a quick look, mostly at USRM's responses to the FDA. My takeaway is there's basically a disagreement regarding the FDA's classification of the patient's stem cells as being considered a product, claims that Comella is the one training the health professionals how to perform their procedures, claims Comella is also creating SOPs for procedures, and a disagreement on how to define adipose tissue.

The FDA's case just seems really weak. No real new info that hasn't already been brought up in this forum. Hopefully just a matter of time before the case is dropped or they settle in a manner acceptable for USRM.